nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—DCLK3—urine—bipolar disorder	0.0237	0.0541	CbGeAlD
Ruxolitinib—RET—autonomic nervous system—bipolar disorder	0.0125	0.0285	CbGeAlD
Ruxolitinib—DCLK3—blood plasma—bipolar disorder	0.0123	0.0282	CbGeAlD
Ruxolitinib—CAMK1—blood plasma—bipolar disorder	0.0102	0.0232	CbGeAlD
Ruxolitinib—MARK2—blood plasma—bipolar disorder	0.00987	0.0226	CbGeAlD
Ruxolitinib—ROCK1—blood plasma—bipolar disorder	0.00718	0.0164	CbGeAlD
Ruxolitinib—MAP3K2—blood plasma—bipolar disorder	0.00567	0.013	CbGeAlD
Ruxolitinib—ANKK1—nervous system—bipolar disorder	0.00521	0.0119	CbGeAlD
Ruxolitinib—CAMK1—adrenal cortex—bipolar disorder	0.00516	0.0118	CbGeAlD
Ruxolitinib—JAK2—blood plasma—bipolar disorder	0.00502	0.0115	CbGeAlD
Ruxolitinib—PRKCE—thyroid gland—bipolar disorder	0.00479	0.011	CbGeAlD
Ruxolitinib—RPS6KA6—thyroid gland—bipolar disorder	0.00461	0.0105	CbGeAlD
Ruxolitinib—TAOK3—blood plasma—bipolar disorder	0.00441	0.0101	CbGeAlD
Ruxolitinib—PRKG2—nervous system—bipolar disorder	0.00432	0.00987	CbGeAlD
Ruxolitinib—JAK1—adrenal cortex—bipolar disorder	0.00423	0.00967	CbGeAlD
Ruxolitinib—GRK1—nervous system—bipolar disorder	0.00412	0.00941	CbGeAlD
Ruxolitinib—DAPK2—adrenal cortex—bipolar disorder	0.00404	0.00923	CbGeAlD
Ruxolitinib—PRKCE—nervous system—bipolar disorder	0.00403	0.00921	CbGeAlD
Ruxolitinib—RPS6KA6—nervous system—bipolar disorder	0.00387	0.00885	CbGeAlD
Ruxolitinib—PLK1—nervous system—bipolar disorder	0.00387	0.00885	CbGeAlD
Ruxolitinib—MAST1—nervous system—bipolar disorder	0.00387	0.00885	CbGeAlD
Ruxolitinib—PLK3—thyroid gland—bipolar disorder	0.00384	0.00878	CbGeAlD
Ruxolitinib—PRKCE—cerebellum—bipolar disorder	0.00379	0.00867	CbGeAlD
Ruxolitinib—CLK2—adrenal cortex—bipolar disorder	0.00376	0.00859	CbGeAlD
Ruxolitinib—DCLK3—nervous system—bipolar disorder	0.00367	0.00839	CbGeAlD
Ruxolitinib—MAST1—cerebellum—bipolar disorder	0.00365	0.00833	CbGeAlD
Ruxolitinib—RPS6KA6—cerebellum—bipolar disorder	0.00365	0.00833	CbGeAlD
Ruxolitinib—CAMK1—thyroid gland—bipolar disorder	0.0036	0.00821	CbGeAlD
Ruxolitinib—MARK2—thyroid gland—bipolar disorder	0.00349	0.00797	CbGeAlD
Ruxolitinib—PRKG2—brain—bipolar disorder	0.0033	0.00754	CbGeAlD
Ruxolitinib—PLK3—nervous system—bipolar disorder	0.00323	0.00739	CbGeAlD
Ruxolitinib—TAOK2—thyroid gland—bipolar disorder	0.00323	0.00738	CbGeAlD
Ruxolitinib—GRK1—brain—bipolar disorder	0.00315	0.00719	CbGeAlD
Ruxolitinib—PRKCE—brain—bipolar disorder	0.00308	0.00704	CbGeAlD
Ruxolitinib—CAMK1—nervous system—bipolar disorder	0.00302	0.00691	CbGeAlD
Ruxolitinib—JAK3—thyroid gland—bipolar disorder	0.00297	0.00678	CbGeAlD
Ruxolitinib—RPS6KA6—brain—bipolar disorder	0.00296	0.00676	CbGeAlD
Ruxolitinib—PLK1—brain—bipolar disorder	0.00296	0.00676	CbGeAlD
Ruxolitinib—MAST1—brain—bipolar disorder	0.00296	0.00676	CbGeAlD
Ruxolitinib—DCLK1—thyroid gland—bipolar disorder	0.00295	0.00674	CbGeAlD
Ruxolitinib—JAK1—thyroid gland—bipolar disorder	0.00295	0.00674	CbGeAlD
Ruxolitinib—MARK2—nervous system—bipolar disorder	0.00294	0.00671	CbGeAlD
Ruxolitinib—CAMK1D—thyroid gland—bipolar disorder	0.00288	0.00658	CbGeAlD
Ruxolitinib—PHKG2—thyroid gland—bipolar disorder	0.00286	0.00654	CbGeAlD
Ruxolitinib—MAP3K7—adrenal cortex—bipolar disorder	0.00285	0.00651	CbGeAlD
Ruxolitinib—CAMK1—cerebellum—bipolar disorder	0.00285	0.0065	CbGeAlD
Ruxolitinib—DAPK2—thyroid gland—bipolar disorder	0.00281	0.00643	CbGeAlD
Ruxolitinib—DCLK3—brain—bipolar disorder	0.00281	0.00641	CbGeAlD
Ruxolitinib—TYK2—adrenal cortex—bipolar disorder	0.0028	0.0064	CbGeAlD
Ruxolitinib—STK16—thyroid gland—bipolar disorder	0.00277	0.00632	CbGeAlD
Ruxolitinib—MKNK2—adrenal cortex—bipolar disorder	0.00276	0.00631	CbGeAlD
Ruxolitinib—MARK2—cerebellum—bipolar disorder	0.00276	0.00631	CbGeAlD
Ruxolitinib—HIPK2—thyroid gland—bipolar disorder	0.00275	0.00629	CbGeAlD
Ruxolitinib—DAPK3—thyroid gland—bipolar disorder	0.00265	0.00604	CbGeAlD
Ruxolitinib—CLK2—thyroid gland—bipolar disorder	0.00262	0.00599	CbGeAlD
Ruxolitinib—CYP3A4—urine—bipolar disorder	0.00257	0.00586	CbGeAlD
Ruxolitinib—TAOK2—cerebellum—bipolar disorder	0.00256	0.00584	CbGeAlD
Ruxolitinib—JAK3—nervous system—bipolar disorder	0.0025	0.0057	CbGeAlD
Ruxolitinib—JAK1—nervous system—bipolar disorder	0.00248	0.00567	CbGeAlD
Ruxolitinib—DCLK1—nervous system—bipolar disorder	0.00248	0.00567	CbGeAlD
Ruxolitinib—DYRK1A—thyroid gland—bipolar disorder	0.00248	0.00566	CbGeAlD
Ruxolitinib—PLK3—brain—bipolar disorder	0.00247	0.00565	CbGeAlD
Ruxolitinib—BMPR2—thyroid gland—bipolar disorder	0.00247	0.00564	CbGeAlD
Ruxolitinib—MAP3K3—adrenal cortex—bipolar disorder	0.00246	0.00561	CbGeAlD
Ruxolitinib—CAMK1D—nervous system—bipolar disorder	0.00242	0.00553	CbGeAlD
Ruxolitinib—PHKG2—nervous system—bipolar disorder	0.00241	0.0055	CbGeAlD
Ruxolitinib—LTK—brain—bipolar disorder	0.00239	0.00545	CbGeAlD
Ruxolitinib—NUAK2—thyroid gland—bipolar disorder	0.00236	0.00539	CbGeAlD
Ruxolitinib—JAK3—cerebellum—bipolar disorder	0.00235	0.00537	CbGeAlD
Ruxolitinib—JAK1—cerebellum—bipolar disorder	0.00233	0.00533	CbGeAlD
Ruxolitinib—DCLK1—cerebellum—bipolar disorder	0.00233	0.00533	CbGeAlD
Ruxolitinib—STK16—nervous system—bipolar disorder	0.00233	0.00532	CbGeAlD
Ruxolitinib—HIPK2—nervous system—bipolar disorder	0.00232	0.00529	CbGeAlD
Ruxolitinib—CAMK1—brain—bipolar disorder	0.00231	0.00528	CbGeAlD
Ruxolitinib—CAMK1D—cerebellum—bipolar disorder	0.00228	0.0052	CbGeAlD
Ruxolitinib—MAP3K19—nervous system—bipolar disorder	0.00227	0.00518	CbGeAlD
Ruxolitinib—PHKG2—cerebellum—bipolar disorder	0.00227	0.00517	CbGeAlD
Ruxolitinib—MARK2—brain—bipolar disorder	0.00224	0.00513	CbGeAlD
Ruxolitinib—TAOK3—adrenal cortex—bipolar disorder	0.00224	0.00511	CbGeAlD
Ruxolitinib—DAPK2—cerebellum—bipolar disorder	0.00223	0.00509	CbGeAlD
Ruxolitinib—DAPK3—nervous system—bipolar disorder	0.00223	0.00508	CbGeAlD
Ruxolitinib—CAMK2G—thyroid gland—bipolar disorder	0.00221	0.00504	CbGeAlD
Ruxolitinib—BMP2K—thyroid gland—bipolar disorder	0.00221	0.00504	CbGeAlD
Ruxolitinib—CLK2—nervous system—bipolar disorder	0.0022	0.00504	CbGeAlD
Ruxolitinib—STK16—cerebellum—bipolar disorder	0.00219	0.005	CbGeAlD
Ruxolitinib—LRRK2—thyroid gland—bipolar disorder	0.00219	0.005	CbGeAlD
Ruxolitinib—HIPK2—cerebellum—bipolar disorder	0.00218	0.00498	CbGeAlD
Ruxolitinib—ROCK1—nervous system—bipolar disorder	0.00214	0.00488	CbGeAlD
Ruxolitinib—DAPK3—cerebellum—bipolar disorder	0.00209	0.00478	CbGeAlD
Ruxolitinib—DYRK1A—nervous system—bipolar disorder	0.00208	0.00476	CbGeAlD
Ruxolitinib—TAOK2—brain—bipolar disorder	0.00208	0.00474	CbGeAlD
Ruxolitinib—BMPR2—nervous system—bipolar disorder	0.00208	0.00474	CbGeAlD
Ruxolitinib—CLK2—cerebellum—bipolar disorder	0.00207	0.00474	CbGeAlD
Ruxolitinib—MAP3K2—thyroid gland—bipolar disorder	0.00201	0.00458	CbGeAlD
Ruxolitinib—MAP3K7—thyroid gland—bipolar disorder	0.00199	0.00454	CbGeAlD
Ruxolitinib—DYRK1A—cerebellum—bipolar disorder	0.00196	0.00448	CbGeAlD
Ruxolitinib—BMPR2—cerebellum—bipolar disorder	0.00195	0.00446	CbGeAlD
Ruxolitinib—TYK2—thyroid gland—bipolar disorder	0.00195	0.00446	CbGeAlD
Ruxolitinib—IRAK1—thyroid gland—bipolar disorder	0.00193	0.0044	CbGeAlD
Ruxolitinib—MKNK2—thyroid gland—bipolar disorder	0.00193	0.0044	CbGeAlD
Ruxolitinib—JAK3—brain—bipolar disorder	0.00191	0.00436	CbGeAlD
Ruxolitinib—JAK1—brain—bipolar disorder	0.0019	0.00433	CbGeAlD
Ruxolitinib—DCLK1—brain—bipolar disorder	0.0019	0.00433	CbGeAlD
Ruxolitinib—PLK4—brain—bipolar disorder	0.00188	0.0043	CbGeAlD
Ruxolitinib—RET—thyroid gland—bipolar disorder	0.00188	0.00429	CbGeAlD
Ruxolitinib—NUAK2—cerebellum—bipolar disorder	0.00187	0.00426	CbGeAlD
Ruxolitinib—CAMK2G—nervous system—bipolar disorder	0.00186	0.00424	CbGeAlD
Ruxolitinib—BMP2K—nervous system—bipolar disorder	0.00186	0.00424	CbGeAlD
Ruxolitinib—CAMK1D—brain—bipolar disorder	0.00185	0.00423	CbGeAlD
Ruxolitinib—LRRK2—nervous system—bipolar disorder	0.00184	0.0042	CbGeAlD
Ruxolitinib—PHKG2—brain—bipolar disorder	0.00184	0.0042	CbGeAlD
Ruxolitinib—DAPK2—brain—bipolar disorder	0.00181	0.00413	CbGeAlD
Ruxolitinib—STK16—brain—bipolar disorder	0.00178	0.00407	CbGeAlD
Ruxolitinib—JAK2—thyroid gland—bipolar disorder	0.00177	0.00405	CbGeAlD
Ruxolitinib—HIPK2—brain—bipolar disorder	0.00177	0.00404	CbGeAlD
Ruxolitinib—BMP2K—cerebellum—bipolar disorder	0.00175	0.00399	CbGeAlD
Ruxolitinib—CAMK2G—cerebellum—bipolar disorder	0.00175	0.00399	CbGeAlD
Ruxolitinib—MAP3K19—brain—bipolar disorder	0.00173	0.00396	CbGeAlD
Ruxolitinib—LRRK2—cerebellum—bipolar disorder	0.00173	0.00396	CbGeAlD
Ruxolitinib—MAP3K3—thyroid gland—bipolar disorder	0.00171	0.00391	CbGeAlD
Ruxolitinib—DAPK3—brain—bipolar disorder	0.0017	0.00389	CbGeAlD
Ruxolitinib—MAP3K2—nervous system—bipolar disorder	0.00169	0.00385	CbGeAlD
Ruxolitinib—CLK2—brain—bipolar disorder	0.00168	0.00385	CbGeAlD
Ruxolitinib—TYK2—nervous system—bipolar disorder	0.00164	0.00375	CbGeAlD
Ruxolitinib—ROCK1—brain—bipolar disorder	0.00163	0.00373	CbGeAlD
Ruxolitinib—MKNK2—nervous system—bipolar disorder	0.00162	0.0037	CbGeAlD
Ruxolitinib—DYRK1A—brain—bipolar disorder	0.00159	0.00364	CbGeAlD
Ruxolitinib—MAP3K2—cerebellum—bipolar disorder	0.00159	0.00362	CbGeAlD
Ruxolitinib—BMPR2—brain—bipolar disorder	0.00159	0.00362	CbGeAlD
Ruxolitinib—RET—nervous system—bipolar disorder	0.00158	0.00361	CbGeAlD
Ruxolitinib—MAP3K7—cerebellum—bipolar disorder	0.00157	0.00359	CbGeAlD
Ruxolitinib—TAOK3—thyroid gland—bipolar disorder	0.00156	0.00356	CbGeAlD
Ruxolitinib—TYK2—cerebellum—bipolar disorder	0.00154	0.00353	CbGeAlD
Ruxolitinib—MKNK2—cerebellum—bipolar disorder	0.00152	0.00348	CbGeAlD
Ruxolitinib—IRAK1—cerebellum—bipolar disorder	0.00152	0.00348	CbGeAlD
Ruxolitinib—NUAK2—brain—bipolar disorder	0.00152	0.00346	CbGeAlD
Ruxolitinib—JAK2—nervous system—bipolar disorder	0.00149	0.00341	CbGeAlD
Ruxolitinib—RET—cerebellum—bipolar disorder	0.00149	0.00339	CbGeAlD
Ruxolitinib—MAP3K3—nervous system—bipolar disorder	0.00144	0.00329	CbGeAlD
Ruxolitinib—CAMK2G—brain—bipolar disorder	0.00142	0.00324	CbGeAlD
Ruxolitinib—BMP2K—brain—bipolar disorder	0.00142	0.00324	CbGeAlD
Ruxolitinib—LRRK2—brain—bipolar disorder	0.00141	0.00321	CbGeAlD
Ruxolitinib—JAK2—cerebellum—bipolar disorder	0.0014	0.00321	CbGeAlD
Ruxolitinib—MAP3K3—cerebellum—bipolar disorder	0.00135	0.00309	CbGeAlD
Ruxolitinib—CYP3A4—blood plasma—bipolar disorder	0.00134	0.00306	CbGeAlD
Ruxolitinib—TAOK3—nervous system—bipolar disorder	0.00131	0.003	CbGeAlD
Ruxolitinib—MAP3K2—brain—bipolar disorder	0.00129	0.00294	CbGeAlD
Ruxolitinib—MAP3K7—brain—bipolar disorder	0.00128	0.00292	CbGeAlD
Ruxolitinib—TYK2—brain—bipolar disorder	0.00125	0.00286	CbGeAlD
Ruxolitinib—IRAK1—brain—bipolar disorder	0.00124	0.00283	CbGeAlD
Ruxolitinib—MKNK2—brain—bipolar disorder	0.00124	0.00283	CbGeAlD
Ruxolitinib—TAOK3—cerebellum—bipolar disorder	0.00123	0.00282	CbGeAlD
Ruxolitinib—RET—brain—bipolar disorder	0.00121	0.00276	CbGeAlD
Ruxolitinib—JAK2—brain—bipolar disorder	0.00114	0.00261	CbGeAlD
Ruxolitinib—MAP3K3—brain—bipolar disorder	0.0011	0.00251	CbGeAlD
Ruxolitinib—TAOK3—brain—bipolar disorder	0.001	0.00229	CbGeAlD
Ruxolitinib—CYP3A4—nervous system—bipolar disorder	0.000398	0.00091	CbGeAlD
Ruxolitinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	4.85e-05	8.62e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TAC1—bipolar disorder	4.85e-05	8.62e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HTR1A—bipolar disorder	4.84e-05	8.61e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—DRD2—bipolar disorder	4.84e-05	8.61e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—GSK3A—bipolar disorder	4.83e-05	8.59e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—NRG1—bipolar disorder	4.81e-05	8.55e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—ADCY2—bipolar disorder	4.8e-05	8.54e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—DRD3—bipolar disorder	4.8e-05	8.54e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TAC1—bipolar disorder	4.77e-05	8.48e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HTR2C—bipolar disorder	4.75e-05	8.46e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—DRD1—bipolar disorder	4.75e-05	8.46e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—GSK3B—bipolar disorder	4.74e-05	8.43e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—DRD5—bipolar disorder	4.72e-05	8.4e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TRPC3—bipolar disorder	4.72e-05	8.4e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—DRD1—bipolar disorder	4.68e-05	8.32e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HTR2C—bipolar disorder	4.68e-05	8.32e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HTR1A—bipolar disorder	4.66e-05	8.29e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—DRD4—bipolar disorder	4.66e-05	8.29e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—ADCY2—bipolar disorder	4.66e-05	8.29e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—ADM—bipolar disorder	4.64e-05	8.25e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RGS4—bipolar disorder	4.63e-05	8.24e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NTRK2—bipolar disorder	4.62e-05	8.23e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—NRG1—bipolar disorder	4.62e-05	8.21e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—GSK3B—bipolar disorder	4.62e-05	8.21e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—DRD3—bipolar disorder	4.6e-05	8.19e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—GSK3B—bipolar disorder	4.6e-05	8.19e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—TAC1—bipolar disorder	4.59e-05	8.17e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—GSK3A—bipolar disorder	4.58e-05	8.15e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—POMC—bipolar disorder	4.58e-05	8.15e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—GSK3B—bipolar disorder	4.58e-05	8.15e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TRPC3—bipolar disorder	4.58e-05	8.15e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—IL1B—bipolar disorder	4.58e-05	8.14e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—INS—bipolar disorder	4.56e-05	8.1e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NTRK2—bipolar disorder	4.55e-05	8.09e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—DRD3—bipolar disorder	4.53e-05	8.05e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TSHB—bipolar disorder	4.52e-05	8.04e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PDE4B—bipolar disorder	4.52e-05	8.04e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TACR1—bipolar disorder	4.52e-05	8.04e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—GSK3A—bipolar disorder	4.51e-05	8.02e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—ADM—bipolar disorder	4.5e-05	8.01e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—DRD1—bipolar disorder	4.5e-05	8.01e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HTR2C—bipolar disorder	4.5e-05	8.01e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—GSK3B—bipolar disorder	4.47e-05	7.96e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—DRD4—bipolar disorder	4.47e-05	7.95e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—GSK3B—bipolar disorder	4.46e-05	7.94e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NRG1—bipolar disorder	4.45e-05	7.92e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—ADCY2—bipolar disorder	4.44e-05	7.89e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—TCF7L2—bipolar disorder	4.42e-05	7.86e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—DRD4—bipolar disorder	4.4e-05	7.82e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TSHB—bipolar disorder	4.39e-05	7.81e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PDE4B—bipolar disorder	4.39e-05	7.81e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TACR1—bipolar disorder	4.39e-05	7.81e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—ADCY2—bipolar disorder	4.39e-05	7.8e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NTRK1—bipolar disorder	4.38e-05	7.79e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—ADM—bipolar disorder	4.37e-05	7.77e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—DRD3—bipolar disorder	4.36e-05	7.76e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—DRD2—bipolar disorder	4.34e-05	7.72e-05	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—POMC—bipolar disorder	4.34e-05	7.72e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—S100B—bipolar disorder	4.31e-05	7.67e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—GSK3B—bipolar disorder	4.29e-05	7.62e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—POMC—bipolar disorder	4.27e-05	7.59e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—S100B—bipolar disorder	4.26e-05	7.58e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PDE4B—bipolar disorder	4.26e-05	7.57e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TSHB—bipolar disorder	4.26e-05	7.57e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TACR1—bipolar disorder	4.26e-05	7.57e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—DRD4—bipolar disorder	4.23e-05	7.53e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—GSK3B—bipolar disorder	4.22e-05	7.51e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—ADCY2—bipolar disorder	4.21e-05	7.48e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TCF7L2—bipolar disorder	4.19e-05	7.46e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—S100B—bipolar disorder	4.18e-05	7.44e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—DRD2—bipolar disorder	4.16e-05	7.41e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—MTHFR—bipolar disorder	4.16e-05	7.4e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—ADCY2—bipolar disorder	4.14e-05	7.36e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TCF7L2—bipolar disorder	4.12e-05	7.33e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—DRD2—bipolar disorder	4.09e-05	7.28e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—S100B—bipolar disorder	4.06e-05	7.22e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—HTR2A—bipolar disorder	4.02e-05	7.14e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—ADCY2—bipolar disorder	3.98e-05	7.09e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—COMT—bipolar disorder	3.98e-05	7.09e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—GSK3A—bipolar disorder	3.97e-05	7.06e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—MAOA—bipolar disorder	3.96e-05	7.04e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—GSK3B—bipolar disorder	3.95e-05	7.03e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—DRD2—bipolar disorder	3.94e-05	7.01e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—POMC—bipolar disorder	3.94e-05	7.01e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metapathway biotransformation—COMT—bipolar disorder	3.93e-05	6.99e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—INS—bipolar disorder	3.9e-05	6.93e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—POMC—bipolar disorder	3.88e-05	6.9e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HLA-E—bipolar disorder	3.81e-05	6.77e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—NRG1—bipolar disorder	3.8e-05	6.77e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—SNAP25—bipolar disorder	3.8e-05	6.76e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NTRK1—bipolar disorder	3.77e-05	6.7e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NRG1—bipolar disorder	3.76e-05	6.69e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR1A—bipolar disorder	3.74e-05	6.66e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NTRK1—bipolar disorder	3.71e-05	6.59e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—NRG1—bipolar disorder	3.69e-05	6.57e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TAC1—bipolar disorder	3.69e-05	6.56e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL1B—bipolar disorder	3.68e-05	6.55e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—S100B—bipolar disorder	3.66e-05	6.52e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—GSK3A—bipolar disorder	3.66e-05	6.51e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—HTR2A—bipolar disorder	3.64e-05	6.48e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—ADCY2—bipolar disorder	3.64e-05	6.48e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR1A—bipolar disorder	3.63e-05	6.46e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—GSK3B—bipolar disorder	3.63e-05	6.46e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR2C—bipolar disorder	3.61e-05	6.43e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—DRD1—bipolar disorder	3.61e-05	6.43e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—S100B—bipolar disorder	3.6e-05	6.41e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—NRG1—bipolar disorder	3.58e-05	6.37e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TRPC3—bipolar disorder	3.58e-05	6.36e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TAC1—bipolar disorder	3.58e-05	6.36e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR1A—bipolar disorder	3.52e-05	6.27e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NTRK2—bipolar disorder	3.52e-05	6.25e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR2C—bipolar disorder	3.51e-05	6.24e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—DRD1—bipolar disorder	3.51e-05	6.24e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—DRD3—bipolar disorder	3.5e-05	6.23e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—GSK3B—bipolar disorder	3.49e-05	6.2e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—GSK3A—bipolar disorder	3.49e-05	6.2e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TAC1—bipolar disorder	3.47e-05	6.17e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ADM—bipolar disorder	3.41e-05	6.07e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NTRK2—bipolar disorder	3.41e-05	6.07e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NRG1—bipolar disorder	3.41e-05	6.06e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—IMPA2—bipolar disorder	3.41e-05	6.06e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR2C—bipolar disorder	3.4e-05	6.05e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—DRD1—bipolar disorder	3.4e-05	6.05e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—DRD4—bipolar disorder	3.4e-05	6.05e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—DRD3—bipolar disorder	3.4e-05	6.05e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—HTR2A—bipolar disorder	3.39e-05	6.03e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—GSK3A—bipolar disorder	3.38e-05	6.02e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL1B—bipolar disorder	3.37e-05	6e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—ADCY2—bipolar disorder	3.36e-05	5.98e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—GSK3B—bipolar disorder	3.35e-05	5.96e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TCF7L2—bipolar disorder	3.35e-05	5.96e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PDE4B—bipolar disorder	3.33e-05	5.92e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TSHB—bipolar disorder	3.33e-05	5.92e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TACR1—bipolar disorder	3.33e-05	5.92e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NTRK2—bipolar disorder	3.31e-05	5.89e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—INS—bipolar disorder	3.31e-05	5.88e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—DRD4—bipolar disorder	3.3e-05	5.87e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—DRD3—bipolar disorder	3.3e-05	5.86e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL1B—bipolar disorder	3.29e-05	5.86e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—GSK3A—bipolar disorder	3.28e-05	5.84e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NRG1—bipolar disorder	3.23e-05	5.75e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—GSK3B—bipolar disorder	3.23e-05	5.75e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—POMC—bipolar disorder	3.21e-05	5.71e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—DRD4—bipolar disorder	3.2e-05	5.69e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—ADCY2—bipolar disorder	3.2e-05	5.69e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—INS—bipolar disorder	3.19e-05	5.67e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TCF7L2—bipolar disorder	3.19e-05	5.67e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NRG1—bipolar disorder	3.18e-05	5.66e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—S100B—bipolar disorder	3.17e-05	5.64e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—DRD2—bipolar disorder	3.17e-05	5.63e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL1B—bipolar disorder	3.11e-05	5.53e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—ADCY2—bipolar disorder	3.11e-05	5.52e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TCF7L2—bipolar disorder	3.09e-05	5.5e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—DRD2—bipolar disorder	3.07e-05	5.47e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—MTHFR—bipolar disorder	3.07e-05	5.46e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—HTR2A—bipolar disorder	3.04e-05	5.41e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—ADCY2—bipolar disorder	3.01e-05	5.36e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TCF7L2—bipolar disorder	3e-05	5.34e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—DRD2—bipolar disorder	2.98e-05	5.3e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HTR2A—bipolar disorder	2.92e-05	5.19e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—POMC—bipolar disorder	2.91e-05	5.18e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HTR2A—bipolar disorder	2.87e-05	5.1e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NTRK1—bipolar disorder	2.87e-05	5.1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—NRG1—bipolar disorder	2.8e-05	4.98e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—S100B—bipolar disorder	2.79e-05	4.96e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NTRK1—bipolar disorder	2.78e-05	4.95e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HTR2A—bipolar disorder	2.76e-05	4.91e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—GSK3B—bipolar disorder	2.76e-05	4.91e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR1A—bipolar disorder	2.75e-05	4.9e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—GSK3B—bipolar disorder	2.73e-05	4.85e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TAC1—bipolar disorder	2.71e-05	4.82e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—POMC—bipolar disorder	2.71e-05	4.82e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—S100B—bipolar disorder	2.71e-05	4.81e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NTRK1—bipolar disorder	2.7e-05	4.8e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—INS—bipolar disorder	2.69e-05	4.79e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—GSK3B—bipolar disorder	2.68e-05	4.77e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL1B—bipolar disorder	2.67e-05	4.75e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR2C—bipolar disorder	2.66e-05	4.73e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—DRD1—bipolar disorder	2.66e-05	4.73e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—S100B—bipolar disorder	2.62e-05	4.67e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—GSK3B—bipolar disorder	2.6e-05	4.62e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NTRK2—bipolar disorder	2.59e-05	4.6e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NRG1—bipolar disorder	2.58e-05	4.6e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—DRD3—bipolar disorder	2.58e-05	4.58e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—POMC—bipolar disorder	2.58e-05	4.58e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—GSK3A—bipolar disorder	2.56e-05	4.56e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—DRD4—bipolar disorder	2.5e-05	4.45e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—GSK3B—bipolar disorder	2.48e-05	4.4e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NRG1—bipolar disorder	2.46e-05	4.37e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—INS—bipolar disorder	2.44e-05	4.34e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—POMC—bipolar disorder	2.43e-05	4.32e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NRG1—bipolar disorder	2.39e-05	4.25e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ADCY2—bipolar disorder	2.35e-05	4.19e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—GSK3B—bipolar disorder	2.35e-05	4.18e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TCF7L2—bipolar disorder	2.35e-05	4.17e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—DRD2—bipolar disorder	2.33e-05	4.14e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—POMC—bipolar disorder	2.33e-05	4.14e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—MTHFR—bipolar disorder	2.33e-05	4.14e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—INS—bipolar disorder	2.32e-05	4.12e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NRG1—bipolar disorder	2.32e-05	4.12e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—GSK3B—bipolar disorder	2.31e-05	4.11e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—IMPA1—bipolar disorder	2.3e-05	4.1e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—POMC—bipolar disorder	2.29e-05	4.07e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—INS—bipolar disorder	2.28e-05	4.05e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR2A—bipolar disorder	2.22e-05	3.94e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—POMC—bipolar disorder	2.21e-05	3.92e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR2A—bipolar disorder	2.15e-05	3.83e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NTRK1—bipolar disorder	2.11e-05	3.75e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR2A—bipolar disorder	2.09e-05	3.71e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—S100B—bipolar disorder	2.05e-05	3.65e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL1B—bipolar disorder	2.03e-05	3.62e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—GSK3B—bipolar disorder	2.03e-05	3.61e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL1B—bipolar disorder	1.97e-05	3.51e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NDUFV2—bipolar disorder	1.96e-05	3.48e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL1B—bipolar disorder	1.91e-05	3.4e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—AKR1C4—bipolar disorder	1.9e-05	3.37e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—GSK3B—bipolar disorder	1.88e-05	3.34e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—INS—bipolar disorder	1.85e-05	3.29e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NRG1—bipolar disorder	1.81e-05	3.22e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—GSK3B—bipolar disorder	1.79e-05	3.18e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—POMC—bipolar disorder	1.77e-05	3.15e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—INS—bipolar disorder	1.76e-05	3.13e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—GSK3B—bipolar disorder	1.73e-05	3.08e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—POMC—bipolar disorder	1.72e-05	3.06e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—INS—bipolar disorder	1.71e-05	3.04e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NR1D1—bipolar disorder	1.7e-05	3.03e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—GSK3B—bipolar disorder	1.68e-05	2.99e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—POMC—bipolar disorder	1.67e-05	2.97e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—INS—bipolar disorder	1.66e-05	2.95e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR2A—bipolar disorder	1.63e-05	2.9e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NCAN—bipolar disorder	1.63e-05	2.9e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC5A3—bipolar disorder	1.6e-05	2.84e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL1B—bipolar disorder	1.5e-05	2.66e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—GSK3B—bipolar disorder	1.31e-05	2.34e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—POMC—bipolar disorder	1.3e-05	2.32e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—INS—bipolar disorder	1.3e-05	2.3e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CLOCK—bipolar disorder	1.15e-05	2.05e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TPH2—bipolar disorder	1.12e-05	2e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CACNB2—bipolar disorder	1.12e-05	2e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TSHB—bipolar disorder	1.12e-05	2e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—DPYD—bipolar disorder	1.11e-05	1.97e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CACNA1C—bipolar disorder	1.03e-05	1.83e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	1e-05	1.78e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SNAP25—bipolar disorder	8.99e-06	1.6e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ADCY2—bipolar disorder	7.96e-06	1.42e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—COMT—bipolar disorder	6.81e-06	1.21e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MAOA—bipolar disorder	6.76e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MTHFR—bipolar disorder	5.51e-06	9.79e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—POMC—bipolar disorder	4.4e-06	7.83e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—INS—bipolar disorder	4.38e-06	7.79e-06	CbGpPWpGaD
